The stock recorded an intraday low of Rs.22.33, reflecting a day’s fall of 4.98%, underperforming its sector by 4.83% on the same trading session. This marks the second consecutive day of losses, with the stock delivering a cumulative return of -6.76% over this period. Roselabs Finance is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish pressure.
In contrast, the broader market has shown resilience. The Sensex opened flat but gained momentum to close at 85,186.47, up 0.61% or 542.69 points, and remains close to its 52-week high of 85,290.06. The Sensex’s 50-day moving average remains above its 200-day moving average, indicating a bullish trend for the benchmark index. Mega-cap stocks led the market rally, highlighting a divergence between large-cap performance and the challenges faced by Roselabs Finance.
Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!
- Complete fundamentals package
- Technical momentum confirmed
- Reasonable valuation entry
Over the past year, Roselabs Finance has delivered a return of -39.63%, significantly lagging behind the Sensex’s 9.81% gain during the same period. The stock’s 52-week high was Rs.39.28, indicating a substantial decline of approximately 43% from that peak. This underperformance extends beyond the last year, with the stock also trailing the BSE500 index over the last three years, one year, and three months.
Financially, the company’s long-term fundamentals present concerns. Roselabs Finance reports a negative book value, which points to weak long-term financial strength. While net sales have shown an annual growth rate of 30.80%, operating profit has remained flat at 0%, indicating limited profitability improvement. The company’s operating cash flow for the fiscal year ended September 2025 was recorded at Rs. -0.32 crore, the lowest in recent periods, reflecting cash flow constraints.
Additionally, the company’s earnings before interest, taxes, depreciation, and amortisation (EBITDA) remain negative, which contributes to the perception of elevated risk compared to its historical valuation averages. Profit figures have declined by 16% over the past year, further underscoring the challenges faced by Roselabs Finance in generating consistent earnings.
Shareholding structure remains concentrated, with promoters holding the majority stake in the company. This ownership pattern is typical for many NBFCs but adds a layer of consideration regarding governance and strategic direction.
Considering Roselabs Finance ? Wait! SwitchER has found potentially better options in Non Banking Financial Company (NBFC) and beyond. Compare this micro-cap with top-rated alternatives now!
- Better options discovered
- Non Banking Financial Company (NBFC) + beyond scope
- Top-rated alternatives ready
Roselabs Finance’s recent price action and financial metrics highlight a period of subdued performance within the NBFC sector. The stock’s position below all major moving averages and its 52-week low price of Rs.22.33 reflect ongoing market caution. Despite the broader market’s positive trajectory, Roselabs Finance’s fundamentals and price trends suggest a need for close monitoring.
Investors analysing Roselabs Finance should note the divergence between the company’s sales growth and profitability metrics, as well as the negative cash flow and EBITDA figures. These factors contribute to the stock’s current valuation challenges and its relative underperformance compared to sector peers and the benchmark indices.
While the Sensex continues to trade near its 52-week high supported by mega-cap strength, Roselabs Finance’s trajectory remains distinct, underscoring the varied dynamics within the NBFC sector and the broader market environment.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
